Coordinated alternative splicing decisions via stepwise exon definition
Nucleic Acids Research · 05.05.2026 · 54 (9)
DOI: 10.1093/nar/gkag464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 19.05.2026. Verfasst von Panajot Kristofori und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, Institute for Biomedical Genetics (IBMG), University of Stuttgart, 70569 Stuttgart, Germany. Hauptthemen laut MEDLINE: Exons, Alternative Splicing. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Alternative splicing of pre-mRNA is a fundamental step in human gene regulation, and aberrant splicing is frequently linked to complex diseases, including cancer. All splicing events, such as skipping or inclusion of an alternative exon (AE) and intron retention (IR), are regulated by a common molecular machinery, the spliceosome. However, it remains elusive how the spliceosome coordinates different splicing decisions. Here, we analyzed a large-scale mutagenesis screen and transcriptome-wide RNA sequencing data to show that intron retention adjacent to alternative exons most commonly occurs at intermediate inclusion levels. Using data-driven mathematical modeling, we revealed that multistep exon recognition mediated by spliceosome assembly and maturation explains the observed AE-IR dependency for cis-acting sequence mutations and upon knockdown of trans-acting RNA-binding proteins. Furthermore, we found that multistep exon recognition is commonly perturbed in a transcriptome-wide manner in cancer cells, which leads to the coordinated deregulation of IR and AE decisions. In total, our work suggests that stepwise alternative exon recognition by the spliceosome coordinates AE inclusion and the retention of flanking introns, which may facilitate the search for common molecular mechanisms for mis-splicing in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Systems Biology, Institute for Biomedical Genetics (IBMG), University of Stuttgart, 70569 Stuttgart, Germany.
- Stuttgart Research Center for Systems Biology (SRCSB), University of Stuttgart, 70569 Stuttgart, Germany.
- Institute of Molecular Biology (IMB), Ackermannweg 4, 55128 Mainz, Germany.
- Buchmann Institute for Molecular Life Sciences (BMLS), Goethe University Frankfurt, Max-von-Laue-Str. 15, 60438 Frankfurt, Germany.
- Theodor Boveri Institute, University Würzburg, Biocenter, Am Hubland, 97074 Würzburg, Germany.
ORCID-Profile: Panajot Kristofori, Zijie Xiao, Simon Braun, Anke Busch, Kathi Zarnack, Julian König, Stefan Legewie, Congxin Li
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Kristofori, P., Xiao, Z., Braun, S., Busch, A., Zarnack, K., König, J., Legewie, S., & Li, C. (2026). Coordinated alternative splicing decisions via stepwise exon definition. Nucleic Acids Research, 54(9). https://doi.org/10.1093/nar/gkag464
Vancouver
Kristofori P, Xiao Z, Braun S, Busch A, Zarnack K, König J, et al. Coordinated alternative splicing decisions via stepwise exon definition. Nucleic Acids Research. 2026;54(9). doi:10.1093/nar/gkag464
BibTeX
@article{Kristofori2026,
author = {Kristofori, Panajot and Xiao, Zijie and Braun, Simon and Busch, Anke and Zarnack, Kathi and König, Julian and Legewie, Stefan and Li, Congxin},
title = {Coordinated alternative splicing decisions via stepwise exon definition},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {9},
doi = {10.1093/nar/gkag464}
}
EUVIMED